SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivo Bio Tech gains getting contract from Biological E

30 Aug 2021 Evaluate

Vivo Bio Tech is currently trading at Rs. 98.00, up by 11.05 points or 12.71% from its previous closing of Rs. 86.95 on the BSE.

The scrip opened at Rs. 99.70 and has touched a high and low of Rs. 99.70 and Rs. 96.30 respectively. So far 27330 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 115.10 on 15-Jun-2021 and a 52 week low of Rs. 30.40 on 08-Oct-2020.

Last one week high and low of the scrip stood at Rs. 90.50 and Rs. 71.00 respectively. The current market cap of the company is Rs. 123.51 crore.

The promoters holding in the company stood at 39.84% while Non-Institutions held 60.16% stake in the company.

Vivo Bio Tech has entered into a long term supply contract for various products & services with Biological E, one of the largest vaccine manufacturers of India, as a preferred vendor. The value of the contract is estimated to be a in the range of Rs 20 crore to Rs 30 crore per year, for each of the next three years.

Vivo Bio Tech was incorporated on February 12, 1987 as Golden Growth Fund, Hyderabad-based Vivo Bio Tech (VBTL) is a contract research company engaged in biotechnology and pharma drug discovery activities.

Vivo Bio Tech Share Price

29.30 0.38 (1.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×